Nicholas Bevins, MD, PhD | Authors


Comparing Impact of Panel Composition on Tumor Mutational Burden Calculation

November 15, 2019

Nicholas Bevins, MD, PhD, discusses the results from an in silico comparison of frequently used next-generation sequencing panels. The analysis aimed to identify the impact of the panel composition on tumor mutational burden calculations. Results from the analysis were presented in a poster at the 2019 Association for Molecular Pathology Annual Meeting and Expo.